Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on chiral reagent. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102911085A details a high-selectivity synthesis route for D-2-aminooxy-3-methylbutyric acid from L-valine, offering cost-effective chiral intermediate manufacturing solutions.
Patent CN102219798A reveals a cost-effective method for high-purity chiral boranes, enabling reliable pharmaceutical intermediates supplier capabilities and reduced manufacturing costs.
Novel patent CN104557600B offers streamlined Sacubitril synthesis. Enhances supply chain reliability and reduces manufacturing complexity for global pharmaceutical partners.
Reduce production costs and environmental impact with >98% ee and 92% yield in asymmetric synthesis of key florfenicol intermediate for pharmaceutical manufacturing.